169 related articles for article (PubMed ID: 33050529)
21. Long-term effect of growth hormone on sleep-disordered breathing in Malaysian children with Prader-Willi syndrome: a retrospective study.
Tan YT; Azanan MS; Hng SY; Eg KP; Jalaludin MY; Thong MK; Tae SK; Samingan N; Anuar A; Nathan AM
J Clin Sleep Med; 2024 Apr; ():. PubMed ID: 38557309
[TBL] [Abstract][Full Text] [Related]
22. Growth Hormone Treatment in Children With Prader-Willi Syndrome: Three Years of Longitudinal Data in Prepubertal Children and Adult Height Data From the KIGS Database.
Bakker NE; Lindberg A; Heissler J; Wollmann HA; Camacho-Hübner C; Hokken-Koelega AC;
J Clin Endocrinol Metab; 2017 May; 102(5):1702-1711. PubMed ID: 28323917
[TBL] [Abstract][Full Text] [Related]
23. Hypogonadism in females with Prader-Willi syndrome from infancy to adulthood: variable combinations of a primary gonadal defect and hypothalamic dysfunction.
Eldar-Geva T; Hirsch HJ; Benarroch F; Rubinstein O; Gross-Tsur V
Eur J Endocrinol; 2010 Feb; 162(2):377-84. PubMed ID: 19946044
[TBL] [Abstract][Full Text] [Related]
24. The natural history of premature adrenarche.
Ghizzoni L; Milani S
J Pediatr Endocrinol Metab; 2000; 13 Suppl 5():1247-51. PubMed ID: 11117663
[TBL] [Abstract][Full Text] [Related]
25. Central precocious puberty in a girl with Prader-Willi syndrome.
Lee HS; Hwang JS
J Pediatr Endocrinol Metab; 2013; 26(11-12):1201-4. PubMed ID: 23740678
[TBL] [Abstract][Full Text] [Related]
26. Primary testicular dysfunction is a major contributor to abnormal pubertal development in males with Prader-Willi syndrome.
Hirsch HJ; Eldar-Geva T; Benarroch F; Rubinstein O; Gross-Tsur V
J Clin Endocrinol Metab; 2009 Jul; 94(7):2262-8. PubMed ID: 19401370
[TBL] [Abstract][Full Text] [Related]
27. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome.
Angulo M; Castro-Magana M; Mazur B; Canas JA; Vitollo PM; Sarrantonio M
J Pediatr Endocrinol Metab; 1996; 9(3):393-400. PubMed ID: 8887149
[TBL] [Abstract][Full Text] [Related]
28. Prader-Willi syndrome, diabetes mellitus and hypogonadism.
Nagai T; Mori M
Biomed Pharmacother; 1999 Dec; 53(10):452-4. PubMed ID: 10665337
[TBL] [Abstract][Full Text] [Related]
29. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
[TBL] [Abstract][Full Text] [Related]
30. Central precocious puberty in Prader-Willi syndrome: a narrative review.
Nicoară DM; Scutca AC; Mang N; Juganaru I; Munteanu AI; Vitan L; Mărginean O
Front Endocrinol (Lausanne); 2023; 14():1150323. PubMed ID: 37251677
[TBL] [Abstract][Full Text] [Related]
31. Hormonal, metabolic and skeletal phenotype of Schaaf-Yang syndrome: a comparison to Prader-Willi syndrome.
McCarthy JM; McCann-Crosby BM; Rech ME; Yin J; Chen CA; Ali MA; Nguyen HN; Miller JL; Schaaf CP
J Med Genet; 2018 May; 55(5):307-315. PubMed ID: 29496979
[TBL] [Abstract][Full Text] [Related]
32. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children.
Bizzarri C; Rigamonti AE; Luce A; Cappa M; Cella SG; Berini J; Sartorio A; Müller EE; Salvatoni A
Eur J Endocrinol; 2010 Mar; 162(3):499-505. PubMed ID: 20019130
[TBL] [Abstract][Full Text] [Related]
33. Sleep-related breathing disorders in patients with Prader-Willi syndrome depending on the period of growth hormone treatment.
Lecka-Ambroziak A; Jędrzejczak M; Wysocka-Mincewicz M; Szalecki M
Endokrynol Pol; 2017; 68(6):676-681. PubMed ID: 29022650
[TBL] [Abstract][Full Text] [Related]
34. Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome.
Massa G; Maes M; Heinrichs C; Vandeweghe M; Craen M; Vanderschueren-Lodeweyckx M
Clin Endocrinol (Oxf); 1993 Mar; 38(3):253-60. PubMed ID: 8458097
[TBL] [Abstract][Full Text] [Related]
35. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
Whitman BY; Myers S; Carrel A; Allen D
Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
[TBL] [Abstract][Full Text] [Related]
36. Pubarche and serum dehydroepiandrosterone sulphate levels in children with Prader-Willi syndrome.
Siemensma EP; de Lind van Wijngaarden RF; Otten BJ; de Jong FH; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2011 Jul; 75(1):83-9. PubMed ID: 21521261
[TBL] [Abstract][Full Text] [Related]
37. Adrenarche in Silver-Russell Syndrome: Timing and Consequences.
Binder G; Schweizer R; Blumenstock G; Ferrand N
J Clin Endocrinol Metab; 2017 Nov; 102(11):4100-4108. PubMed ID: 28945864
[TBL] [Abstract][Full Text] [Related]
38. One-year follow-up of thyroid function in 23 infants with Prader- Willi syndrome at a single center in China.
Yang M; Ye J; Han L; Qiu W; Yu Y; Gu X; Zhang H
Intractable Rare Dis Res; 2021 Aug; 10(3):198-201. PubMed ID: 34466342
[TBL] [Abstract][Full Text] [Related]
39. Childhood metabolic syndrome and its components in premature adrenarche.
Utriainen P; Jääskeläinen J; Romppanen J; Voutilainen R
J Clin Endocrinol Metab; 2007 Nov; 92(11):4282-5. PubMed ID: 17698912
[TBL] [Abstract][Full Text] [Related]
40. Polymorphism Pro12Ala of PPARG in prepubertal children with premature adrenarche and its association with growth in healthy children.
Laakso S; Utriainen P; Laakso M; Voutilainen R; Jääskeläinen J
Horm Res Paediatr; 2010; 74(5):365-71. PubMed ID: 20606394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
